Evidence map›Paper›PMID 35054355›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Generalization Challenges in Drug-Resistant Tuberculosis Detection from Chest X-rays.

Manohar Karki, Karthik Kantipudi, Feng Yang, Hang Yu, Yi Xiang J Wang, Ziv Yaniv, Stefan Jaeger

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Automated Pulmonary Tuberculosis Severity Assessment on Chest X-rays.Journal of imaging informatics in medicine · 2024
    Article
  5. Semantically redundant training data removal and deep model classification performance: A study with chest X-rays.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2024
    Article
  6. Tuberculosis Chest X-Ray Image Retrieval System Using Deep Learning Based Biomarker Predictions.Proceedings of SPIE--the International Society for Optical Engineering · 2024
    Article
  7. Article
  8. Combining Radiological and Genomic TB Portals Data for Drug Resistance Analysis.IEEE access : practical innovations, open solutions · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manohar KarkiLister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, Bethesda, MD 20894, USA.ORCID 0000-0002-0353-9728
Karthik KantipudiOffice of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20894, USA.ORCID 0000-0002-6423-1647
Feng YangLister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, Bethesda, MD 20894, USA.ORCID 0000-0002-8334-7450
Hang YuLister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, Bethesda, MD 20894, USA.
Yi Xiang J WangLister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, Bethesda, MD 20894, USA.ORCID 0000-0001-5697-0717
Ziv YanivOffice of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20894, USA.ORCID 0000-0003-0315-7727
Stefan JaegerLister Hill National Center for Biomedical Communications, U.S. National Library of Medicine, Bethesda, MD 20894, USA.ORCID 0000-0001-6877-4318

Funding

Federal funds from the531 National Institute of Allergy and Infectious Diseases under BCBB Support Services Contract HHSN316201300006W/HHSN27200002Office of the Secretary Patient-Centered528 Outcomes Research Trust Fund 750119PE080057
6 · The paper itself

Abstract

Classification of drug-resistant tuberculosis (DR-TB) and drug-sensitive tuberculosis (DS-TB) from chest radiographs remains an open problem. Our previous cross validation performance on publicly available chest X-ray (CXR) data combined with image augmentation, the addition of synthetically generated and publicly available images achieved a performance of 85% AUC with a deep convolutional neural network (CNN). However, when we evaluated the CNN model trained to classify DR-TB and DS-TB on unseen data, significant performance degradation was observed (65% AUC). Hence, in this paper, we investigate the generalizability of our models on images from a held out country's dataset. We explore the extent of the problem and the possible reasons behind the lack of good generalization. A comparison of radiologist-annotated lesion locations in the lung and the trained model's localization of areas of interest, using GradCAM, did not show much overlap. Using the same network architecture, a multi-country classifier was able to identify the country of origin of the X-ray with high accuracy (86%), suggesting that image acquisition differences and the distribution of non-pathological and non-anatomical aspects of the images are affecting the generalization and localization of the drug resistance classification model as well. When CXR images were severely corrupted, the performance on the validation set was still better than 60% AUC. The model overfitted to the data from countries in the cross validation set but did not generalize to the held out country. Finally, we applied a multi-task based approach that uses prior TB lesions location information to guide the classifier network to focus its attention on improving the generalization performance on the held out set from another country to 68% AUC.

Indexed as

chest X-raysdeep learningdrug resistancegeneralizationlocalizationTuberculosis (TB)

Identifiers

PMID35054355
PMCPMC8775073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.